ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters 2: Speed Matters… or Does it? How Fast is Fast Enough for Antibiotics in Septic Children?

Cameron Berg, MD and Drew Kalnow, DO

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Pediatric sepsis care still favors early antibiotics, but this large multicenter study suggests sepsis-attributable mortality does not begin to climb until antibiotic delay extends well beyond the familiar 3-hour benchmark. In children with suspected sepsis, diagnosis, resuscitation, source control, and disposition remain at least as important as reflexively pushing antibiotics first.

Pediatric Sepsis Antibiotic Timing

  • Multicenter mortality inflection: Across 51 US children's hospitals, sepsis-related 3-day mortality began to rise at 330 minutes from sepsis recognition, a much later signal than many clinicians would expect.
  • Guideline tension point: Current pediatric sepsis guidance still cites antibiotics within 1 hour for shock and within 3 hours for sepsis, but this dataset challenges how rigidly that 3-hour rule should be applied.
  • Early treatment confounding: Children treated in the first 29 minutes had higher mortality than those treated later, a classic marker of confounding by indication rather than proof that faster antibiotics are harmful.
  • Outcome pattern nuance: Delayed antibiotics beyond the inflection point were linked to higher 3-day and 30-day sepsis mortality, yet ICU admission, ventilator use, and vasoactive support did not clearly differ.
  • Recognition time anchor: The study used First Time Zero within 1 hour of ED arrival as the sepsis recognition anchor, an important operational detail when interpreting any time-to-antibiotic target. We get into why that definition matters in the episode.
  • Practice-changing takeaway: Antibiotics still matter in pediatric sepsis, but the bigger bedside priority may be targeted diagnosis, resuscitation, and source control instead of blindly front-loading antimicrobials.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty